Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 201 to 250 of 379

TitlePrioritisation programmeDecisionDecision date
Echolaser for BPHNone selectedNot selected
Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]None selectedNot selected
Selective internal radiation therapy for unresectable colorectal metastases in the liverNone selectedNot selected
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827]None selectedNot selected
Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 [TSID10767]None selectedNot selected
Coronary venous arterialisation in patients with refractory anginaNone selectedNot selected
Lateral orbital decompressionNone selectedNot selected
Perfusion-induced systemic hyperthermia for the treatment of advanced lung cancerNone selectedNot selected
Endovascular Arch RepairNone selectedNot selected
Innovative treatment of leakage and anastomotic insufficiencyNone selectedAwaiting decision
Subcutaneous ravulizumab for treating paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome [TSID11820]None selectedNot selected
CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria [TSID11832]None selectedNot selected
Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788]None selectedNot selected
Subcutaneous efgartigmod for treating generalised myasthenia gravis [TSID11835]None selectedNot selected
NPJ5008 for treating malignant hyperthermia [TSID11829]None selectedNot selected
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)None selectedNot selected
Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)None selectedNot selected
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasisNone selectedNot selected
Vascular RoboticsNone selectedNot selected
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsyNone selectedNot selected
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasisNone selectedNot selected
Focused Electrohydraulic Shockwaves for wound healingNone selectedNot selected
Advanced Pelvic Exenteration surgery for complex pelvic cancersNone selectedNot selected
Extradural motor cortex stimulation (EMCS) for Parkinson's diseaseNone selectedFurther information required
Magnetic compression anastomosis for rectal atresiaNone selectedFurther information required
Emicizumab for preventing bleeding episodes in people with mild or moderate haemophilia A [ID5098]None selectedNot selected
Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639]None selectedNot selected
Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819]None selectedNot selected
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]None selectedNot selected
EUS guided portal pressure measurementNone selectedAwaiting decision
Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]None selectedNot selected
Aflibercept for untreated diabetic macular oedema [TSID10621]None selectedNot selected
High-dose aflibercept for treating wet age-related macular degeneration [TSID10590]None selectedNot selected
High intensity focused electromagnetic (HIFEM) energy to target the pelvic floor musclesNone selectedNot selected
Transcranial direct current stimulation (tDCS) for the treatment of refractory epilepsyNone selectedFurther information required
Semaglutide for treating type 2 diabetes and associated peripheral arterial disease [TSID11791]None selectedNot selected
Stockholm3 blood test for prostate cancer, (MT734),None selectedNot selected
Percutaneous Laser (Photo) Ablation of Liver TumoursNone selectedAwaiting decision
Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761]None selectedNot selected
Sacubitril valsartan for treating chronic heart failure with reduced ejection fraction in people under 18 years [TSID10350]None selectedNot selected
Circcurer CircumcisionNone selectedNot selected
Advanced pelvic exenteration / high complexity pelvic exenterationNone selectedAwaiting decision
Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years [TSID11805]None selectedNot selected
O2Matic pro 100 (MT746)None selectedNot selected
Signatera molecular residual disease assay (MT741)None selectedNot selected
ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790]None selectedNot selected
DV7103 for treating cystinuria in people 6 months and over [TSID10438]None selectedFurther information required
Polydioxanone stents for the therapy of Tracheal stenosis: adultsNone selectedAwaiting decision
Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]None selectedNot selected
Canakinumab for untreated Schnitzler syndrome [ID4063]None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All